Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: Combination therapy with c-met inhibitor and TRAIL enhances apoptosis in dedifferentiated liposarcoma patient-derived cells

Fig. 5

Death receptor 5 was upregulated in DDLPS cells upon PF c-Met inhibitor treatment. Expression levels of DR4 (a) and DR5 (b) in LPS224 and LPS246 cells after 24 h and 48 h of incubation with PF measured via FACS. The left panel shows control cells with DMSO (shaded gray histogram) and the right panel shows cells treated with 10 μM PF (bold black open histogram)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us